PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor.

Green, S H; Rydel, Russell E.; Connolly, JL; Greene, Lloyd A.

doi:10.1083/jcb.102.3.830

Cited by 274 publications

(169 citation statements)

References 64 publications

Supporting

Mentioning

164

Contrasting

Order By: Relevance

“…It is quite reasonable to ask whether these pathways are involved in the down-regulation of WT1. To test this possibility, three cell lines were used: PC12nnr5, a cell line that expresses very little or no p140 trk , the high affinity receptor for NGF (11); and two PC12 cell variants that express dominant-negative forms of Ras (M-M17-26) and Src (SrcDN2), respectively (12,13). When cells were treated with NGF for 5 days, expression levels of both WT1 and EGFR were decreased dramatically in wild-type PC12 cells.…”

Section: Ngf-induced Down-regulation Of Wt1 Is P140mentioning

confidence: 99%

“…In all experiments involving extended treatment with NGF, the medium was changed, and fresh NGF was added every other day. PC12nnr5 cells (11) were grown in RPMI 1640 medium (Life Technologies, Inc.) supplemented with 5% fetal bovine serum and 10% horse serum. The PC12 cell variants M-M17-26 expressing the Ha-ras Asn-17 gene under the transcriptional control of the mouse metallothionein-I promoter (12) and srcDN2 expressing the K295R mutant (kinase-inactive) form of chicken Src under the control of the cytomegalovirus (CMV) promoter (13) were grown, as were PC12 cells, in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum and 10% horse serum.…”

mentioning

confidence: 99%

See 1 more Smart Citation

The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells

Liu¹,

Gong²,

Guo³

et al. 2001

Journal of Biological Chemistry

View full text Add to dashboard Cite

Recently, we characterized the rat epidermal growth factor receptor (EGFR) promoter and demonstrated that TCC repeat sequences are required for the downregulation of EGFR by nerve growth factor (NGF) in PC12 cells. In this study, we report that the Wilms' tumor gene product WT1, a zinc finger transcription factor, is able to enhance the activity of the rat EGFR promoter in cotransfection assays. Gel mobility shift assays demonstrate that WT1 binds to the TCC repeat sequences of the rat EGFR promoter. Overexpression of WT1 resulted in up-regulation of the expression levels of endogenous EGFR in PC12 cells. Interestingly, NGF down-regulated the expression levels of WT1 and EGFR in PC12 cells, but not in the p140 trk -deficient variant PC12nnr5 cells or in cells expressing either dominantnegative Ras or dominant-negative Src. Most importantly, we evaluated the inhibitory effect of antisense WT1 RNA on EGFR expression, and we found that antisense WT1 RNA could substantially reduce EGFR repression in either histochemical staining study or immunoblot analysis. These results indicate that NGFinduced down-regulation of the EGFR in PC12 cells is mediated through WT1 and that WT1 may play an important role in the differentiation of nerve cells. The epidermal growth factor receptor (EGFR)1 is a member of the ErbB family of ligand-activated tyrosine kinase receptors, which play a central role in the proliferation, differentiation, and/or oncogenesis of epithelial cells, neural cells, and fibroblasts (1). Some years ago, we reported that PC12 cells respond to both epidermal growth factor (EGF) and nerve growth factor (NGF), but that the response to epidermal growth factor is mitogenic, whereas the response to nerve growth factor leads to differentiation (2). It was of interest to determine what would happen if the cells were exposed to both stimuli at the same time. The answer was that the cells simply did not respond to EGF after they had been treated with NGF, and the reason that they did not respond is that the EGFR is markedly down-regulated by treatment of the cells with NGF (3).Our studies have focused on the molecular mechanism by which NGF down-regulates the EGFR. Previous studies have demonstrated that NGF-induced down-regulation of the EGFR was at the transcriptional level (4) and that the down-regulation is p140 trk -, Ras-, and Src-dependent (5). Recently, we isolated and characterized the rat EGFR promoter region and found that TCC repeat sequences in the promoter region of the rat EGFR are required for the down-regulation of rat EGFR by NGF during the differentiation of PC12 cells (6).WT1, the Wilms' tumor suppressor gene, is located at chromosome locus 11p13 and encodes a zinc finger protein that is one of several transcription factors that have been found to interact with TCC repeat sequences (7-9). Experimental evidence has indicated that WT1 not only plays a role during kidney development but is also involved in the development and homeostasis of other tissues. The products of WT1 have been implicated in va...

show abstract

Section: Ngf-induced Down-regulation Of Wt1 Is P140mentioning

confidence: 99%

mentioning

confidence: 99%

The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells

Liu¹,

Gong²,

Guo³

et al. 2001

Journal of Biological Chemistry

View full text Add to dashboard Cite

show abstract

“…To study the ability of TrkA point mutants to induce di erentiation in the presence or absence of NGF, we transfected the cDNA encoding the mutant receptors into the PC12nnr5 cell line. This mutant cell line was derived from PC12 cells and lost the expression of endogenous TrkA receptors (Green et al, 1986). The cDNAs, cloned in the pCDNA3 plasmid, were co-transfected with an expression plasmid carrying the lacZ gene (pCMV-lacZ).…”

Section: Abstract: Receptor; Tyrosine Kinases; Dimerization; Cell Tramentioning

confidence: 99%

A novel mutation within the extracellular domain of TrkA causes constitutive receptor activation

et al. 2001

View full text Add to dashboard Cite

The TrkA NGF receptor extracellular region contains three leucine repeats¯anked by cysteine clusters and two immunoglobulin-like domains that are required for speci®c ligand binding. Deletion of the immunoglobulinlike domains abolishes NGF binding and causes ligand independent activation of the receptor. Here we report a speci®c mutation that increases the binding a nity of the TrkA receptor for NGF. A change of proline 203 to alanine (P203A) in the linker region between the leucine repeats and the ®rst Ig-like domain increased NGF binding by decreasing the ligand rate of dissociation. This mutated receptor was appropriately expressed on the cell surface and promoted ligand-independent neurite outgrowth in PC12nnr5 cells. The mutant receptor was capable of spontaneous dimerization and was constitutively phosphorylated in the absence of ligand. Moreover, expression of TrkA-P203A receptor in ®broblasts induced DNA synthesis and transformation and generated tumours in nude mice. These data suggest that domains outside of the immunoglobulin-like structure contribute to ligand binding and constitutive activation of Trk receptors. Oncogene (2001) 20, 1229 ± 1234.

show abstract

“…In this study, we have used a number of PC12 variant cell lines with different levels of p140 trk (12,13) and EGF receptor expression and dominant-negative Ras (7,14,15) or Src (5,6,8) PC12 transfectants in an attempt to elucidate the molecular mechanisms of the receptor cross-talk required by NGF to down-regulate EGF receptors. Our findings implicate the involvement of p140 trk -, Ras-, and Src-dependent signaling pathways in NGF-induced down-regulation of EGF receptors while * The costs of publication of this article were defrayed in part by the payment of page charges.…”

mentioning

confidence: 99%

Down-regulation of Epidermal Growth Factor Receptors by Nerve Growth Factor in PC12 Cells Is p140 -, Ras-, and Src-dependent

Lazarovici

Oshima

Shavit

et al. 1997

Journal of Biological Chemistry

View full text Add to dashboard Cite

PC12 cells, derived from a rat pheochromocytoma, have been extensively used as a model of neuronal differentiation (1), because the cells acquire the phenotype of sympathetic neurons and stop dividing in response to nerve growth factor (NGF) 1 (2).In PC12 cells, NGF interacts with two distinct plasma membrane receptor proteins: p75 NGFR , a cysteine-rich glycoprotein having a relatively low affinity for NGF (3), and p140 trk , a receptor tyrosine kinase activated by NGF, which binds NGF with high affinity and mediates many of the biological activities of this neurotrophin (4). The binding of NGF to the p140 trk receptor stimulates rapid tyrosine autophosphorylation of the receptor and activation of several signal-transducing proteins (4). Activated p140 trk receptors bind to and tyrosine phosphorylate the signaling substrates phospholipase C␥1, phosphatidylinositol-3 kinase, and Src homologous collagen protein (4), resulting in their activation. The latter stimulates Ras activity which subsequently activates a series of serine/threonine kinases including B-Raf, myelin basic protein kinase kinase, the Erks, and p90 rsk (4). This Ras-Erk pathway plays a major role in the activation of transcriptional events by NGF and in NGFinduced neuronal differentiation (5), as illustrated by inhibition of NGF actions upon expression of dominant-negative HaRas (Asn-17) proteins (6, 7). In addition a role for pp60 c-src in NGF actions has been suggested (5) by experiments involving the expression of a dominant-interfering kinase-inactive Src (8).PC12 cells also express plasma membrane receptors for epidermal growth factor (EGF) (9, 10), a mild mitogen for these cells (9). PC12 cells treated with NGF exhibit an attenuated response to EGF (9) because EGF receptors are down-regulated (9, 11). The cellular mechanisms that mediate NGF-induced EGF receptor down-regulation are unknown and represent an interesting question in neuronal development. The existence of functional receptors for both NGF and EGF on PC12 cells and the recent advances in understanding the signaling pathways activated by these receptors make these cells a useful model for the study of cross-regulation between NGF and EGF receptors during differentiation.In this study, we have used a number of PC12 variant cell lines with different levels of p140 trk (12, 13) and EGF receptor expression and dominant-negative Ras (7,14,15) or Src (5,6,8) PC12 transfectants in an attempt to elucidate the molecular mechanisms of the receptor cross-talk required by NGF to down-regulate EGF receptors. Our findings implicate the involvement of p140 trk -, Ras-, and Src-dependent signaling pathways in NGF-induced down-regulation of EGF receptors while * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ‡ Permanent address:

show abstract

PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor.

Cited by 274 publications

References 64 publications

The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells

The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells

A novel mutation within the extracellular domain of TrkA causes constitutive receptor activation

Down-regulation of Epidermal Growth Factor Receptors by Nerve Growth Factor in PC12 Cells Is p140 -, Ras-, and Src-dependent

Contact Info

Product

Resources

About